Baird Downgrades Diversey Hldgs to Neutral, Announces $8.5 Price Target

Baird analyst Andrew Wittmann downgrades Diversey Hldgs (NASDAQ:DSEY) from Outperform to Neutral and announces $8.5 price target.

Baird analyst Andrew Wittmann downgrades Diversey Hldgs (NASDAQ:DSEY) from Outperform to Neutral and announces $8.5 price target.

Total
0
Shares
Related Posts
Read More

Azitra, Inc. Announces Preclinical Data From The Co’s Platform And Pipeline On Friday, May 10, 2024, In Two Oral Sessions Entitled “Engineered Staphylococcus Epidermidis As A Protein Delivery System For Treating Skin Diseases” And “Staphylococcus Epide…

Azitra will present two oral presentations at ASGCT (American Society of Gene and Cell Therapy) Baltimore, MD, May 7-11, 2024 related to ATR-12, Azitra's candidate for Netherton syndromeTopical application of ATR-12 to

AZTR